Pediatric Gastroenterology & Hepatology focuses on the prevention, diagnosis, and management of gastrointestinal, liver, pancreatic, and nutritional disorders in infants, children, and adolescents. As a key theme of the Global Gastroenterology, Liver Diseases & Hepatology Conference & Industry Expo, this track brings together pediatric gastroenterologists, hepatologists, surgeons, researchers, industry leaders, and healthcare innovators from around the world.
The sessions will address advances in pediatric digestive and liver diseases, including early diagnosis, personalized treatment strategies, novel therapeutics, minimally invasive procedures, and long-term disease management. Special emphasis will be placed on translational research, pediatric clinical trials, and child-centered care models.
This forum also promotes innovation, investment, and industry partnerships, encouraging collaboration between academia, pharmaceutical and biotech companies, medical device manufacturers, and digital health innovators to improve outcomes in pediatric patients.
Join global experts to exchange knowledge, explore emerging technologies, and build partnerships that will shape the future of pediatric gastroenterology and hepatology care worldwide.
Sub Topics: Pediatric inflammatory bowel disease, Pediatric liver diseases, Neonatal cholestasis, Pediatric hepatology diagnostics, Pediatric endoscopy, Pediatric gastrointestinal motility disorders, Pediatric functional GI disorders, Pediatric celiac disease, Pediatric food allergies, Pediatric eosinophilic gastrointestinal disorders, Pediatric viral hepatitis, Pediatric autoimmune liver diseases, Pediatric metabolic liver disorders, Pediatric fatty liver disease, Pediatric cirrhosis management, Pediatric portal hypertension, Pediatric biliary atresia, Pediatric liver transplantation, Pediatric pancreatitis, Pediatric pancreatic disorders, Pediatric nutrition and malnutrition, Pediatric short bowel syndrome, Pediatric intestinal failure, Pediatric gut microbiome, Pediatric GI infections, Pediatric GI oncology, Pediatric colorectal disorders, Pediatric GI bleeding, Pediatric congenital GI anomalies, Pediatric abdominal pain management, Pediatric diarrhea management, Pediatric constipation and motility, Pediatric feeding disorders, Pediatric GERD, Pediatric peptic ulcer disease, Pediatric hepatobiliary imaging, Pediatric genetic GI disorders, Pediatric rare liver diseases, Pediatric clinical trials, Pediatric precision medicine, Pediatric biologics and therapeutics, Pediatric endoscopic innovations, Pediatric minimally invasive surgery, Pediatric digital health solutions, Pediatric patient-centered care, Pediatric transition to adult care, Pediatric public health gastroenterology, Pediatric vaccination and liver health, Pediatric global GI health
Keynote Points:
High prevalence of H. pylori infection globally
Demand for rapid, accurate, and non-invasive diagnostic tests
Opportunities in antibiotics, combination therapies, and treatment kits
Test-and-treat models reduce healthcare costs and improve patient compliance
Potential integration with telemedicine, digital tracking, and patient education platforms
Collaboration opportunities with hospitals, clinics, and laboratory networks
Increasing awareness campaigns driving early detection and preventive care
Benefits:
Access to a large, recurring patient base with digestive disorders
Strong ROI potential through diagnostics, treatment kits, and preventive programs
Differentiation through innovative, patient-centric care models
Supports preventive healthcare initiatives and public health campaigns
Opportunities for partnerships across pharma, diagnostics, and digital health
Long-term growth potential with scalable, standardized test-and-treat solutions
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com